Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Zocdoc raises $150 million
New York-based digital healthcare marketplace Zocdoc announced $150 million in growth financing from Francisco Partners, a […]
Personal Genome Diagnostics Announces Close of $103 Million Series C Financing
Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the close of […]
Panxora leads $1.5m USD medical blockchain token fundraising
Panxora Digital Ventures, part of the Panxora Group announces it will lead token investment syndicate […]
Pill Connect secures £0.5m to take electronic smart pill bottle that monitors patient adherence to commercial launch
Pill Connect, formerly known as Elucid mHealth, has completed a £510,000 funding round with the […]
Surging Nanotech Investments Boost Global Healthcare and Pandemic Protection
COVID-19’s outbreak has coincided with investments flooding into nanotech-based healthcare companies, according to Pitchbook‘s latest […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more